OBJECTIVE: To examine the relationship of free testosterone (FT) and sex hormone-binding globulin (SHBG) with insulin resistance and diabetes mellitus (DM) in HIV disease. DESIGN: Cross-sectional analysis from 322 HIV-uninfected and 534 HIV-infected men in the Multicenter AIDS Cohort Study. METHODS: : The main outcomes were DM and homeostasis model assessment-insulin resistance (HOMA-IR). DM was defined as fasting serum glucose ≥126 or self-reported DM and use of DM medications. HOMA-IR was calculated from fasting serum glucose and fasting insulin. RESULTS: Compared with HIV-uninfected men in our sample, HIV-infected men were younger, with lower body mass index, and more often black. HIV-infected men had lower FT (P < 0.001) and higher SHBG (P < 0.0001). The adjusted odds ratio for DM was 1.98 (95% confidence interval: 1.04 to 3.78); mean adjusted log HOMA-IR was 0.21 units higher in HIV-infected men (P < 0.0001). Log SHBG, but not log FT, was associated with DM (odds ratio = 0.44, 95% confidence interval: 0.25 to 0.80) in both groups. Log FT and log SHBG were inversely related to insulin resistance (P < 0.05 for both) independent of HIV. CONCLUSIONS: Compared with HIV-uninfected men, HIV-infected men had lower FT, higher SHBG, and more insulin resistance and DM. Lower FT and lower SHBG were associated with insulin resistance regardless of HIV serostatus. This suggests that sex hormones play a role in the pathogenesis of glucose abnormalities among HIV-infected men.
OBJECTIVE: To examine the relationship of free testosterone (FT) and sex hormone-binding globulin (SHBG) with insulin resistance and diabetes mellitus (DM) in HIV disease. DESIGN: Cross-sectional analysis from 322 HIV-uninfected and 534 HIV-infectedmen in the Multicenter AIDS Cohort Study. METHODS: : The main outcomes were DM and homeostasis model assessment-insulin resistance (HOMA-IR). DM was defined as fasting serum glucose ≥126 or self-reported DM and use of DM medications. HOMA-IR was calculated from fasting serum glucose and fasting insulin. RESULTS: Compared with HIV-uninfectedmen in our sample, HIV-infectedmen were younger, with lower body mass index, and more often black. HIV-infectedmen had lower FT (P < 0.001) and higher SHBG (P < 0.0001). The adjusted odds ratio for DM was 1.98 (95% confidence interval: 1.04 to 3.78); mean adjusted log HOMA-IR was 0.21 units higher in HIV-infectedmen (P < 0.0001). Log SHBG, but not log FT, was associated with DM (odds ratio = 0.44, 95% confidence interval: 0.25 to 0.80) in both groups. Log FT and log SHBG were inversely related to insulin resistance (P < 0.05 for both) independent of HIV. CONCLUSIONS: Compared with HIV-uninfectedmen, HIV-infectedmen had lower FT, higher SHBG, and more insulin resistance and DM. Lower FT and lower SHBG were associated with insulin resistance regardless of HIV serostatus. This suggests that sex hormones play a role in the pathogenesis of glucose abnormalities among HIV-infectedmen.
Authors: Elizabeth Selvin; Manning Feinleib; Lei Zhang; Sabine Rohrmann; Nader Rifai; William G Nelson; Adrian Dobs; Shehzad Basaria; Sherita Hill Golden; Elizabeth A Platz Journal: Diabetes Care Date: 2007-02 Impact factor: 19.112
Authors: Rita Basu; Chiara Dalla Man; Marco Campioni; Ananda Basu; K Sreekumaran Nair; Michael D Jensen; Sundeep Khosla; George Klee; Gianna Toffolo; Claudio Cobelli; Robert A Rizza Journal: Diabetes Care Date: 2007-05-11 Impact factor: 19.112
Authors: Amy Fleischman; Stine Johnsen; David M Systrom; Mirko Hrovat; Christian T Farrar; Walter Frontera; Kathleen Fitch; Bijoy J Thomas; Martin Torriani; Hélène C F Côté; Steven K Grinspoon Journal: Am J Physiol Endocrinol Metab Date: 2007-02-06 Impact factor: 4.310
Authors: S A Paul Chubb; Zoë Hyde; Osvaldo P Almeida; Leon Flicker; Paul E Norman; Konrad Jamrozik; Graeme J Hankey; Bu B Yeap Journal: Eur J Endocrinol Date: 2008-06 Impact factor: 6.664
Authors: Phyllis C Tien; Michael F Schneider; Stephen R Cole; Alexandra M Levine; Mardge Cohen; Jack DeHovitz; Mary Young; Jessica E Justman Journal: AIDS Date: 2007-08-20 Impact factor: 4.177
Authors: Mathis Grossmann; Merlin C Thomas; Sianna Panagiotopoulos; Ken Sharpe; Richard J Macisaac; Sophie Clarke; Jeffrey D Zajac; George Jerums Journal: J Clin Endocrinol Metab Date: 2008-03-04 Impact factor: 5.958
Authors: Michael Reid; Yifei Ma; Rebecca Scherzer; Jennifer C Price; Audrey L French; Michael W Plankey; Carl Grunfeld; Phyllis C Tien Journal: AIDS Date: 2017-01-28 Impact factor: 4.177
Authors: Laurence Slama; Lisa P Jacobson; Xiuhong Li; Frank J Palella; Joseph B Margolick; Lawrence A Kingsley; Dorothy J Wiley; Gilles Pialoux; Adrian S Dobs; Todd T Brown Journal: J Acquir Immune Defic Syndr Date: 2016-01-01 Impact factor: 3.731
Authors: Lauren E Mellor-Crummey; Jordan E Lake; Holly Wilhalme; Chi-Hong Tseng; Philip M Grant; Kristine M Erlandson; Jennifer C Price; Frank J Palella; Larry A Kingsley; Matthew Budoff; Wendy S Post; Todd T Brown Journal: J Clin Gastroenterol Hepatol Date: 2018-07-30
Authors: Anne K Monroe; Adrian S Dobs; Frank J Palella; Lawrence A Kingsley; Mallory D Witt; Todd T Brown Journal: AIDS Res Ther Date: 2014-01-22 Impact factor: 2.250
Authors: Anna L Goldman; Shalender Bhasin; Frederick C W Wu; Meenakshi Krishna; Alvin M Matsumoto; Ravi Jasuja Journal: Endocr Rev Date: 2017-08-01 Impact factor: 25.261